I read it depends on customer trials and cost studies before they decide which way to go as this should give indicated rate of return on the plant which will influence the funding decision on wether to buy in or take royalties only, and funding options available due to rate or return and perhaps customer contracts for supply. I suspect they’d prefer to buy in for bigger slice of pie should the cost studies etc point in that direction is how I’m reading this. Clear the parties have close working relationship, this extension of time very good news as allows work to complete and guide funding on any buy in decision, I feel Primobius will want to get maximum exposure early into these plants to increase income, this gives the time needed to complete DD on FID etc is my reading of it, very good Ann let’s see how it plays, Loop.
NMT Price at posting:
87.5¢ Sentiment: Buy Disclosure: Held
